The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125401413 12540141 3 F 20160913 20160708 20160926 EXP NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-119808 RANBAXY 63.00 YR F Y 0.00000 20160926 OT GB NL

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125401413 12540141 1 PS AMITRIPTYLINE AMITRIPTYLINE 1 Unknown 25 MG, DAILY Y 40816 25 MG
125401413 12540141 2 SS Amitriptyline AMITRIPTYLINE 1 Unknown 10 MG, DAILY Y 40816 10 MG
125401413 12540141 3 SS Amoxicillin + Clavulanate AMOXICILLINCLAVULANATE POTASSIUM 1 Unknown QID Y 0 Q6H
125401413 12540141 4 SS Amoxicillin + Clavulanate AMOXICILLINCLAVULANATE POTASSIUM 1 Intravenous (not otherwise specified) QID Y 0 Q6H
125401413 12540141 5 SS CLINDAMYCIN CLINDAMYCINCLINDAMYCIN PHOSPHATE 1 Unknown 300 MG, QID Y 0 300 MG Q6H
125401413 12540141 6 SS CLONIDINE. CLONIDINE 1 Oral 0.15 MG, TID Y 0 .15 MG Q8H
125401413 12540141 7 SS DIAZEPAM. DIAZEPAM 1 Oral 5 MG, TID Y 0 5 MG Q8H
125401413 12540141 8 SS MORPHINE MORPHINE 1 Intrathecal 3.5 MG, DAILY Y 0 3.5 MG
125401413 12540141 9 SS Morphine MORPHINE 1 Intrathecal 0.5 MG, DAILY Y 0 .5 MG
125401413 12540141 10 SS DUROGESIC FENTANYL 1 Transdermal 100 ?G HOURLY Y 0
125401413 12540141 11 SS OXYCONTIN OXYCODONE HYDROCHLORIDE 1 Oral 20 MG, QID Y 0 20 MG Q6H
125401413 12540141 12 C PROPOFOL. PROPOFOL 1 Unknown UNK Y 0
125401413 12540141 13 C SUFENTANIL SUFENTANIL 1 Unknown UNK Y 0
125401413 12540141 14 C ROCURONIUM ROCURONIUM BROMIDE 1 Unknown UNK Y 0
125401413 12540141 15 C SEVOFLURANE. SEVOFLURANE 1 Unknown UNK Y 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125401413 12540141 1 Amputation stump pain
125401413 12540141 2 Amputation stump pain
125401413 12540141 3 Product used for unknown indication
125401413 12540141 4 Product used for unknown indication
125401413 12540141 5 Product used for unknown indication
125401413 12540141 6 Pain
125401413 12540141 7 Muscle spasms
125401413 12540141 8 Amputation stump pain
125401413 12540141 9 Amputation stump pain
125401413 12540141 10 Pain
125401413 12540141 11 Pain
125401413 12540141 12 General anaesthesia
125401413 12540141 13 General anaesthesia
125401413 12540141 14 General anaesthesia
125401413 12540141 15 General anaesthesia

Outcome of event

Event ID CASEID OUTC COD
125401413 12540141 OT
125401413 12540141 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125401413 12540141 Drug withdrawal syndrome
125401413 12540141 Hemiparesis
125401413 12540141 Posterior reversible encephalopathy syndrome

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found